Publications by: Tan N. Doan

Also publishes as (Tan Doan, T.N. Doan)

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0 [feed] RSS 2.0
Number of items: 6.

Doan, Tan N., Fox, Greg J., Meehan, Michael T., Scott, Nick, Ragonnet, Romain, Viney, Kerri, Trauer, James M., and McBryde, Emma S. (2019) Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study. Journal of Antimicrobial Chemotherapy, 74 (1). pp. 218-227.

Doan, T.N., Varleva, T., Zamfirova, M., Tyufekchieva, M., Keshelava, A., Hristov, K., Yaneva, A., Gadzheva, B., Zhang, S., Irbe, S., Ragonnet, R., McBryde, E.S., and Trauer, J.M. (2019) Strategic investment in tuberculosis control in the Republic of Bulgaria. Epidemiology and Infection, 147. e304.

Ragonnet, Romain, Underwood, Frank, Doan, Tan, Rafai, Eric, Trauer, James, and McBryde, Emma (2019) Strategic planning for tuberculosis control in the Republic of Fiji. Tropical Medicine and Infectious Disease, 4 (2). 71.

Doan, Tan N., Cao, Pengxing, Emeto, Theophilus I., Mccaw, James M., and McBryde, Emma S. (2018) Predicting the outcomes of new short-course regimens for multi-drug resistant tuberculosis using intrahost and pharmacokinetic-pharmacodynamic modelling. Antimicrobial Agents and Chemotherapy, 62 (12). e01487-18.

McBryde, Emma S., Meehan, Michael T., Doan, Tan N., Ragonnet, Romain, Marais, Ben J., Guernier, Vanina, and Trauer, James M. (2017) The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains. International Journal of Infectious Diseases, 56. pp. 14-20.

Doan, Tan N., Eisen, Damon P., Rose, Morgan T., Slack, Andrew, Stearnes, Grace, and McBryde, Emma S. (2017) Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: a latent-class analysis. PLoS One, 12 (11). e0188631.

This list was generated on Sat May 30 04:15:52 2020 AEST.